These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23171856)

  • 41. Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
    Van Poznak C; Reynolds EL; Estilo CL; Hu M; Schneider BP; Hertz DL; Gersch C; Thibert J; Thomas D; Banerjee M; Rae JM; Hayes DF
    Oral Dis; 2022 Jan; 28(1):193-201. PubMed ID: 33274559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
    Wang X; Yu T; Liao X; Yang C; Han C; Zhu G; Huang K; Yu L; Qin W; Su H; Liu X; Peng T
    Cancer Med; 2018 Apr; 7(4):966-980. PubMed ID: 29479826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.
    Campbell JM; Stephenson MD; Bateman E; Peters MD; Keefe DM; Bowen JM
    Pharmacogenomics J; 2017 Jan; 17(1):21-28. PubMed ID: 27503581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.
    Kim JH; Ko YJ; Kim JY; Oh Y; Hwang J; Han S; Kim S; Lee JH; Han DH
    PLoS One; 2015; 10(2):e0118084. PubMed ID: 25668207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
    Such E; Cervera J; Terpos E; Bagán JV; Avaria A; Gómez I; Margaix M; Ibañez M; Luna I; Cordón L; Roig M; Sanz MA; Dimopoulos MA; de la Rubia J
    Haematologica; 2011 Oct; 96(10):1557-9. PubMed ID: 21685474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.
    Katz J; Gong Y; Salmasinia D; Hou W; Burkley B; Ferreira P; Casanova O; Langaee TY; Moreb JS
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):605-11. PubMed ID: 21396799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.
    Sarasquete ME; García-Sanz R; Marín L; Alcoceba M; Chillón MC; Balanzategui A; Santamaria C; Rosiñol L; de la Rubia J; Hernandez MT; Garcia-Navarro I; Lahuerta JJ; González M; San Miguel JF
    Blood; 2008 Oct; 112(7):2709-12. PubMed ID: 18594024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.
    Balla B; Vaszilko M; Kósa JP; Podani J; Takács I; Tóbiás B; Nagy Z; Lazáry A; Lakatos P
    Oral Dis; 2012 Sep; 18(6):580-5. PubMed ID: 22339777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis.
    Zhong DN; Wu JZ; Li GJ
    Acta Haematol; 2013; 129(2):90-5. PubMed ID: 23171856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
    Sarasquete ME; González M; San Miguel JF; García-Sanz R
    Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.